ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of Alternative and Approved Dosing Regimens of Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Participants With Relapsed/Refractory Multiple Myeloma

GlaxoSmithKline
ClinicalTrials.gov · Datasets · License: Public Domain
Open Source ↗
multiplemyeloma
multiple myeloma
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 267997
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.